These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7891281)

  • 21. A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions.
    Rao VM; Lin M; Larive CK; Southard MZ
    J Pharm Sci; 1997 Oct; 86(10):1132-7. PubMed ID: 9344170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Volume to dissolve applied dose (VDAD) and apparent dissolution rate (ADR): tools to predict in vivo bioavailability from orally applied drug suspensions.
    Muenster U; Pelzetter C; Backensfeld T; Ohm A; Kuhlmann T; Mueller H; Lustig K; Keldenich J; Greschat S; Göller AH; Gnoth MJ
    Eur J Pharm Biopharm; 2011 Aug; 78(3):522-30. PubMed ID: 21315152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a reaction-limited model of dissolution: application to official dissolution tests experiments.
    Dokoumetzidis A; Papadopoulou V; Valsami G; Macheras P
    Int J Pharm; 2008 May; 355(1-2):114-25. PubMed ID: 18206324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
    Li M; Lin M; Rustum A
    J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Added release time in diffusion/dissolution coupled release.
    Nuxoll E
    Int J Pharm; 2015 Oct; 494(1):195-204. PubMed ID: 26276252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling of drug release from matrix systems involving moving boundaries: approximate analytical solutions.
    Lee PI
    Int J Pharm; 2011 Oct; 418(1):18-27. PubMed ID: 21251957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro percutaneous permeation of betamethasone and betamethasone 17-valerate.
    Kubota K; Maibach HI
    J Pharm Sci; 1993 Oct; 82(10):1039-45. PubMed ID: 8254489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of corticoids from oleaginous ointment bases containing drug in suspension.
    Chowhan ZT; Pritchard R
    J Pharm Sci; 1975 May; 64(5):754-9. PubMed ID: 1151642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Numerical modelling of transdermal delivery from matrix systems: parametric study and experimental validation with silicone matrices.
    Snorradóttir BS; Jónsdóttir F; Sigurdsson ST; Másson M
    J Pharm Sci; 2014 Aug; 103(8):2366-75. PubMed ID: 24984880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution.
    Tinke AP; Vanhoutte K; De Maesschalck R; Verheyen S; De Winter H
    J Pharm Biomed Anal; 2005 Oct; 39(5):900-7. PubMed ID: 16023816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma concentrations of betamethasone after topical application of betamethasone 17-valerate: comparison with oral administration.
    Kubota K; Lo ES; Huttinot G; Andersen PH; Maibach HI
    Br J Clin Pharmacol; 1994 Jan; 37(1):86-8. PubMed ID: 8148226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of particle dissolution rate on ocular drug bioavailability.
    Hui HW; Robinson JR
    J Pharm Sci; 1986 Mar; 75(3):280-7. PubMed ID: 3701612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determining degree of saturation after application of transiently supersaturated metered dose aerosols for topical delivery of corticosteroids.
    Jones SA; Reid ML; Brown MB
    J Pharm Sci; 2009 Feb; 98(2):543-54. PubMed ID: 18548616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops.
    Loftsson T; Hreinsdóttir D; Stefánsson E
    J Pharm Pharmacol; 2007 May; 59(5):629-35. PubMed ID: 17524227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mechanistic study of danazol dissolution in ionic surfactant solutions.
    Sun W; Larive CK; Southard MZ
    J Pharm Sci; 2003 Feb; 92(2):424-35. PubMed ID: 12532392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of polymers on dissolution from drug suspensions.
    Shah NB; Sheth BB
    J Pharm Sci; 1976 Nov; 65(11):1618-23. PubMed ID: 11332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
    Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L
    Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro dissolution testing of parenteral aqueous solutions and oily suspensions of paracetamol and prednisolone.
    Probst M; Schmidt M; Tietz K; Klein S; Weitschies W; Seidlitz A
    Int J Pharm; 2017 Oct; 532(1):519-527. PubMed ID: 28935252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mathematical modelling of the release of drug from porous, nonswelling transdermal drug-delivery devices.
    Lee AJ; King JR; Hibberd S
    IMA J Math Appl Med Biol; 1998 Jun; 15(2):135-63. PubMed ID: 9661281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery.
    Zoubari G; Staufenbiel S; Volz P; Alexiev U; Bodmeier R
    Eur J Pharm Biopharm; 2017 Jan; 110():39-46. PubMed ID: 27810471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.